A new study has quantified a concern that geriatric specialists have raised for years: the more prescription drugs an older adult takes, the greater the danger. Researchers reported that seniors taking five or more prescriptions faced a 38% higher risk of death than those taking fewer. The finding puts a hard number on the hazards of stacking medications and adds urgency to efforts to trim the long lists of pills that many older patients accumulate over a lifetime.
What polypharmacy means and how common it is
Doctors use the term polypharmacy to describe the routine use of multiple medications by a single patient, most often defined as taking five or more drugs at once. The situation is widespread among older adults, who tend to develop several chronic conditions as they age and to see multiple specialists, each of whom may add a prescription without a full view of the whole regimen. Over time, a patient can end up taking a dozen or more medications daily.
The problem is rarely the result of any single careless decision. Each drug may be prescribed for a legitimate reason by a physician acting appropriately in the moment. The danger emerges from the accumulation, as prescriptions pile up across years and providers, and no one steps back to weigh the combined burden against the benefit of each component.
The 38% figure and what the study measured
The central finding is stark. Older adults taking five or more prescription drugs faced a 38% higher risk of death compared with peers on fewer medications, according to the study. The result translates a familiar clinical worry into a measurable elevation in mortality, giving physicians and patients a concrete sense of the stakes involved in a growing medication list.
A finding of this kind reflects an association between the number of drugs and the risk of death across a studied population, rather than proof that each additional pill directly causes harm in every case. Sicker patients naturally take more medications, and untangling how much of the risk stems from the drugs themselves and how much from the underlying illness is part of the challenge in this field. Even so, the magnitude of the association is large enough to command attention.
How multiple drugs multiply the danger
Several mechanisms help explain why a long medication list can be hazardous in its own right. Every additional drug introduces the possibility of an interaction, in which one medication amplifies, blunts, or otherwise alters the effect of another. As the number of drugs rises, the number of possible interactions grows faster still, and the combinations quickly exceed what any single prescriber can easily track.
Aging bodies also process drugs differently. The kidneys and liver, which clear medications from the body, tend to become less efficient with age, so drugs and their byproducts can linger longer and build to higher levels than intended. That shift makes older adults more susceptible to side effects and to the cascade in which a symptom caused by one drug is mistaken for a new ailment and treated with yet another prescription.
The prescribing cascade and adverse events
One of the most insidious drivers of polypharmacy is the prescribing cascade, in which the side effect of one medication is interpreted as a fresh medical problem and met with an additional drug rather than a reassessment of the original. A medication that raises blood pressure, for instance, might prompt a new prescription to lower it, when reconsidering the first drug would have been the safer course.
The consequences extend beyond mortality statistics. Adverse drug events are a well-documented cause of falls, confusion, hospitalizations, and emergency room visits among older adults. Some medications carry sedating or blood-pressure effects that raise the risk of a fall, an event that can be catastrophic for a frail senior and set off a spiral of decline. The mortality figure captures the most severe outcomes, but the everyday toll of a bloated regimen is broader.
Why medication reviews are gaining ground
The study reinforces a growing push within medicine toward systematic medication reviews and deprescribing, the careful process of identifying and stopping drugs that may no longer help or may be causing harm. Rather than treating each prescription as permanent, the approach asks whether a given drug still serves the patient’s current goals and whether its risks have come to outweigh its benefits.
Deprescribing is meant to be a deliberate, supervised process, not an invitation for patients to abandon their medications on their own. Stopping certain drugs abruptly can be dangerous, and any changes are meant to happen under a clinician’s guidance. The aim is to right-size a regimen so that each remaining medication earns its place, reducing the interaction load without sacrificing needed treatment.
What older patients and caregivers can take from it
For older adults and the family members who help manage their care, the study’s practical message is to treat a growing pill list as something worth periodically questioning rather than accepting as an inevitable feature of aging. Keeping a complete, current list of every medication, including over-the-counter products and supplements, gives a physician the full picture needed to spot redundancies and risky combinations.
Bringing that list to a doctor or pharmacist and asking whether every drug is still necessary is the kind of routine check that specialists encourage. The 38% figure is a reminder that in medicine, more is not always better, and that a candid review of a medication regimen can be one of the most consequential conversations an older patient has.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
